CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-07 | Cotroneo Pat Executive Advisor & Former CFO | Shares withheld for taxes | −2,141 | $12.41 | $27K | 274,536 |
| 2021-06-15 | Cotroneo Pat SVP, Finance and CFO | Sale | −4,053 | $25.62 | $104K | 276,677 |
| 2021-06-07 | Cotroneo Pat SVP, Finance and CFO | Shares withheld for taxes | −2,141 | $22.90 | $49K | 280,730 |
| 2021-03-08 | Cotroneo Pat SVP, Finance and CFO | Shares withheld for taxes | −5,657 | $33.37 | $189K | 282,187 |
| 2021-02-24 | Cotroneo Pat SVP, Finance and CFO | Grant or award | +21,700 | 287,844 | ||
| 2021-02-24 | Cotroneo Pat SVP, Finance and CFO | Grant or award · Stock Option (Right to Buy) | +41,700 | 41,700 | ||
| 2020-12-15 | Cotroneo Pat SVP, Finance and CFO | Sale | −3,068 | $43.60 | $134K | 266,144 |
| 2020-12-07 | Cotroneo Pat SVP, Finance and CFO | Shares withheld for taxes | −3,014 | $41.99 | $127K | 269,212 |
| 2020-09-15 | Cotroneo Pat SVP, Finance and CFO | Sale | −3,070 | $43.63 | $134K | 272,226 |
| 2020-09-08 | Cotroneo Pat SVP, Finance and CFO | Shares withheld for taxes | −3,014 | $42.16 | $127K | 275,296 |
| 2020-09-03 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion | +637 | $29.66 | $19K | 278,947 |
| 2020-09-03 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion | +5,696 | $19.39 | $110K | 284,643 |
| 2020-09-03 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion | +8,671 | $25.40 | $220K | 293,314 |
| 2020-09-03 | Cotroneo Pat SVP, Finance and CFO | Sale | −15,004 | $50.91 | $764K | 278,310 |
| 2020-09-03 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion · Stock Option (Right to Buy) | −637 | 4,618 | ||
| 2020-09-03 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion · Stock Option (Right to Buy) | −5,696 | 0 | ||
| 2020-09-03 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion · Stock Option (Right to Buy) | −8,671 | 41,579 | ||
| 2020-08-11 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion | +3,750 | $19.39 | $73K | 274,810 |
| 2020-08-11 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion | +3,500 | $18.00 | $63K | 278,310 |
| 2020-08-11 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion · Stock Option (Right to Buy) | −3,750 | 5,696 |
Page 1 of 3 · 45 trades